89 related articles for article (PubMed ID: 24806432)
1. Extracellular signal-regulated kinase signaling-mediated induction and interaction of FOXO3a and p53 contribute to the inhibition of nasopharyngeal carcinoma cell growth by curcumin.
Wu J; Tang Q; Zhao S; Zheng F; Wu Y; Tang G; Hahn SS
Int J Oncol; 2014 Jul; 45(1):95-103. PubMed ID: 24806432
[TBL] [Abstract][Full Text] [Related]
2. An aqueous extract of Fagonia cretica induces DNA damage, cell cycle arrest and apoptosis in breast cancer cells via FOXO3a and p53 expression.
Lam M; Carmichael AR; Griffiths HR
PLoS One; 2012; 7(6):e40152. PubMed ID: 22761954
[TBL] [Abstract][Full Text] [Related]
3. Curcumin Nicotinate Selectively Induces Cancer Cell Apoptosis and Cycle Arrest through a P53-Mediated Mechanism.
He YC; He L; Khoshaba R; Lu FG; Cai C; Zhou FL; Liao DF; Cao D
Molecules; 2019 Nov; 24(22):. PubMed ID: 31752145
[TBL] [Abstract][Full Text] [Related]
4. Amyloid aggregates induced by the p53-R280T mutation lead to loss of p53 function in nasopharyngeal carcinoma.
Li J; Guo M; Chen L; Chen Z; Fu Y; Chen Y
Cell Death Dis; 2024 Jan; 15(1):35. PubMed ID: 38212344
[TBL] [Abstract][Full Text] [Related]
5. Curcumin stabilizes p53 by interaction with NAD(P)H:quinone oxidoreductase 1 in tumor-derived cell lines.
Patiño-Morales CC; Soto-Reyes E; Arechaga-Ocampo E; Ortiz-Sánchez E; Antonio-Véjar V; Pedraza-Chaverri J; García-Carrancá A
Redox Biol; 2020 Jan; 28():101320. PubMed ID: 31526948
[TBL] [Abstract][Full Text] [Related]
6. Effects of Ulinastatin on Proliferation and Apoptosis of Breast Cancer Cells by Inhibiting the ERK Signaling Pathway.
Xing Z; Wang X; Liu J; Liu G; Zhang M; Feng K; Wang X
Biomed Res Int; 2021; 2021():9999268. PubMed ID: 34373837
[TBL] [Abstract][Full Text] [Related]
7. IQ Motif Containing GTPase-Activating Protein 3 (IQGAP3) Inhibits Kaempferol-Induced Apoptosis in Breast Cancer Cells by Extracellular Signal-Regulated Kinases 1/2 (ERK1/2) Signaling Activation.
Hu G; Liu H; Wang M; Peng W
Med Sci Monit; 2019 Oct; 25():7666-7674. PubMed ID: 31605603
[TBL] [Abstract][Full Text] [Related]
8. Foxo3a expression and acetylation regulate cancer cell growth and sensitivity to cisplatin.
Shiota M; Yokomizo A; Kashiwagi E; Tada Y; Inokuchi J; Tatsugami K; Kuroiwa K; Uchiumi T; Seki N; Naito S
Cancer Sci; 2010 May; 101(5):1177-85. PubMed ID: 20210796
[TBL] [Abstract][Full Text] [Related]
9. Potent FOXO3a Activators from Biologically Active Compound Library for Cancer Therapeutics: An in silico Approach.
Manoharan S; Vedagiri H; Perumal E
Appl Biochem Biotechnol; 2023 Aug; 195(8):4995-5018. PubMed ID: 37017892
[TBL] [Abstract][Full Text] [Related]
10. Curcumin inhibits human cancer cell growth and migration through downregulation of SVCT2.
Jang SY; Kim J; Hong E; Lee K; Na Y; Yeom CH; Park S
Cell Biochem Funct; 2023 Aug; 41(6):696-703. PubMed ID: 37322603
[TBL] [Abstract][Full Text] [Related]
11. Cisplatin effect on head and neck squamous cell carcinoma cells is modulated by ERK1/2 protein kinases.
Bostan M; Petrică-Matei GG; Ion G; Radu N; Mihăilă M; Hainăroşie R; Braşoveanu LI; Roman V; Constantin C; Neagu MT
Exp Ther Med; 2019 Dec; 18(6):5041-5051. PubMed ID: 31798724
[TBL] [Abstract][Full Text] [Related]
12. NRF2 activation in BON‑1 neuroendocrine cancer cells reduces the cytotoxic effects of a novel Ruthenium(II)‑curcumin compound: A pilot study.
Garufi A; Pettinari R; Monteonofrio L; Puliani G; Virdia I; Appetecchia M; Marchetti F; Cirone M; Soddu S; D'Orazi G
Oncol Rep; 2024 Feb; 51(2):. PubMed ID: 38186307
[TBL] [Abstract][Full Text] [Related]
13. Morusinol Extracted from
Zhang X; Dong Z; Yang Y; Liu C; Li J; Sun W; Zhu Y; Shen Y; Wang Z; Lü M; Cui H
J Agric Food Chem; 2023 Nov; 71(43):16016-16031. PubMed ID: 37870273
[TBL] [Abstract][Full Text] [Related]
14. Role and regulation of FOXO3a: new insights into breast cancer therapy.
Mei W; Mei B; Chang J; Liu Y; Zhou Y; Zhu N; Hu M
Front Pharmacol; 2024; 15():1346745. PubMed ID: 38505423
[TBL] [Abstract][Full Text] [Related]
15. Role of curcumin in regulating p53 in breast cancer: an overview of the mechanism of action.
Talib WH; Al-Hadid SA; Ali MBW; Al-Yasari IH; Ali MRA
Breast Cancer (Dove Med Press); 2018; 10():207-217. PubMed ID: 30568488
[TBL] [Abstract][Full Text] [Related]
16. Curcumin exerts inhibitory effects on undifferentiated nasopharyngeal carcinoma by inhibiting the expression of miR-125a-5p.
Gao W; Chan JY; Wong TS
Clin Sci (Lond); 2014 Nov; 127(9):571-9. PubMed ID: 24896104
[TBL] [Abstract][Full Text] [Related]
17. Curcumin suppresses invasiveness and vasculogenic mimicry of squamous cell carcinoma of the larynx through the inhibition of JAK-2/STAT-3 signaling pathway.
Hu A; Huang JJ; Jin XJ; Li JP; Tang YJ; Huang XF; Cui HJ; Xu WH; Sun GB
Am J Cancer Res; 2015; 5(1):278-88. PubMed ID: 25628937
[TBL] [Abstract][Full Text] [Related]
18. Curcumin and wikstroflavone B, a new biflavonoid isolated from Wikstroemia indica, synergistically suppress the proliferation and metastasis of nasopharyngeal carcinoma cells via blocking FAK/STAT3 signaling pathway.
Shao M; Lou D; Yang J; Lin M; Deng X; Fan Q
Phytomedicine; 2020 Dec; 79():153341. PubMed ID: 32992086
[TBL] [Abstract][Full Text] [Related]
19. Curcumin Inhibits Proliferation of Epstein-Barr Virus-Associated Human Nasopharyngeal Carcinoma Cells by Inhibiting EBV Nuclear Antigen 1 Expression.
Liu L; Yang J; Ji W; Wang C
Biomed Res Int; 2019; 2019():8592921. PubMed ID: 31687403
[TBL] [Abstract][Full Text] [Related]
20. Curcumin exerts its antitumor activity through regulation of miR-7/Skp2/p21 in nasopharyngeal carcinoma cells.
Feng S; Wang Y; Zhang R; Yang G; Liang Z; Wang Z; Zhang G
Onco Targets Ther; 2017; 10():2377-2388. PubMed ID: 28496336
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
